Literature DB >> 15843560

Negative regulation of lymphocyte activation by the adaptor protein LAX.

Minghua Zhu1, Olivia Granillo, Renren Wen, Kaiyong Yang, Xuezhi Dai, Demin Wang, Weiguo Zhang.   

Abstract

The membrane-associated adaptor protein LAX is a linker for activation of T cells (LAT)-like molecule that is expressed in lymphoid tissues. Upon stimulation of T or B cells, it is phosphorylated and interacts with Grb2 and the p85 subunit of PI3K. LAX, however, is not capable of replacing LAT in the TCR signaling pathway. In this study we report that upon T or B cell activation, the LAX protein was up-regulated dramatically. Although disruption of the LAX gene by homologous recombination had no major impact on lymphocyte development, it caused a significant reduction in CD23 expression on mature B cells. Interestingly, naive LAX(-/-) mice had spontaneous germinal center formation. Compared with normal T and B cells, LAX(-/-) T and B cells were hyperresponsive and had enhanced calcium flux, protein tyrosine phosphorylation, MAPK and Akt activation, and cell survival upon engagement of the T or B AgRs. Our data demonstrate that LAX functions as a negative regulator in lymphocyte signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15843560     DOI: 10.4049/jimmunol.174.9.5612

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.

Authors:  Edgar D Charles; Claudia Brunetti; Svetlana Marukian; Kimberly D Ritola; Andrew H Talal; Kristen Marks; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2011-03-18       Impact factor: 22.113

2.  Normal T-cell development and immune functions in TRIM-deficient mice.

Authors:  Uwe Kölsch; Börge Arndt; Dirk Reinhold; Jonathan A Lindquist; Nicole Jüling; Stefanie Kliche; Klaus Pfeffer; Eddy Bruyns; Burkhart Schraven; Luca Simeoni
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

3.  Phosphorylation at serine 318 is not required for inhibition of T cell activation by ALX.

Authors:  Michael J Shapiro; Lynn Spruce; Rhianna Sundsbak; Puspa Thapa; Virginia Smith Shapiro
Journal:  Biochem Biophys Res Commun       Date:  2010-05-13       Impact factor: 3.575

4.  Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation.

Authors:  Harvey E Johnston; Matthew J Carter; Marta Larrayoz; James Clarke; Spiro D Garbis; David Oscier; Jonathan C Strefford; Andrew J Steele; Renata Walewska; Mark S Cragg
Journal:  Mol Cell Proteomics       Date:  2018-01-24       Impact factor: 5.911

5.  Negative regulation of interleukin-2 and p38 mitogen-activated protein kinase during T-cell activation by the adaptor ALX.

Authors:  Claire E Perchonock; Melissa C Fernando; William J Quinn; Chau T Nguyen; Jing Sun; Michael J Shapiro; Virginia Smith Shapiro
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

Review 6.  A tale of two TRAPs: LAT and LAB in the regulation of lymphocyte development, activation, and autoimmunity.

Authors:  Deirdre M Fuller; Minghua Zhu; Chih-Wen Ou-Yang; Sarah A Sullivan; Weiguo Zhang
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 7.  Regulation of lymphocyte development and activation by the LAT family of adapter proteins.

Authors:  Deirdre M Fuller; Weiguo Zhang
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

Review 8.  Adapters in the organization of mast cell signaling.

Authors:  Damiana Alvarez-Errico; Eva Lessmann; Juan Rivera
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

9.  Negative regulation of TCR signaling by linker for activation of X cells via phosphotyrosine-dependent and -independent mechanisms.

Authors:  Michael J Shapiro; Chau T Nguyen; Haig Aghajanian; Weiguo Zhang; Virginia Smith Shapiro
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  129/SvJ mice have mutated CD23 and hyper IgE.

Authors:  Jill W Ford; Jamie L Sturgill; Daniel H Conrad
Journal:  Cell Immunol       Date:  2008-10-01       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.